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Early assessment of outcome of pituitary surgery for 
Cushing’s disease
Ad R. Hermus
Department of Endocrinology, University Hospital 
Nijmegen, 6500 HB Nijmegen, The Netherlands
In recent years selective pituitary adenomectomy by trans­
sphenoidal microsurgery has become the treatment o f choice 
for Cushing’s disease. However, it is not successful in all 
patients. Recently, the European Cushing’s Disease Survey 
Study Group has reported on 668 patients with Cushing’s 
disease from 25 institutions throughout Europe treated with 
transsphenoidal surgery between 1975 and 1990 (Bochicchio et 
al., 1995). clinical and biochemical remission of 
hypercortisolism after surgery occurred in 76-3% of patients. 
Unfortunately, not all o f the patients in remission after surgery 
were really cured: the disease recurred at a mean time o f 39-3 
months in 12-7% o f 510 patients who were in remission after 
the operation. The distribution o f the recurrences did not show  
any plateau or cluster throughout the follow-up period, so it 
may be expected that with longer follow-up more relapses will 
be observed.
Accurate early assessment o f outcome o f pituitary surgery 
for Cushing’s disease is important to expedite further treatment 
in patients with persistent hypercortisolism. Patients in whom  
the morning serum cortisol level and/or 24-hour urinary cortisol 
excretion are above the normal range in the early postoperative 
period (5--14 days o f surgery) are considered surgical failures. 
They have to be referred for further treatment, e.g. early repeat 
surgery (Ram et a l ., 1994) or pituitary irradiation (Estrada et 
ill., 1997). On the contrary, the finding of a morning serum 
cortisol level and 24-hour urinary cortisol excretion clearly 
below normal, especially when accompanied by symptoms o f  
secondary adrenocortical insufficiency, will almost invariably
a clinical remission of Cushing’s disease. 
However, a small number of patients in whom pituitary surgery 
induces a remission o f the disease are not hypocortisolaemic 
immediately after surgery: serum cortisol may decline only 
gradually to a level below normal in patients with adrenal 
macronodules and a period o f hypocortisolaemia after surgery 
may even be lacking completely in patients with periodic 
hypersecretion o f cortisol or in those receiving medical 
treatment to lower their cortisol production before surgery 
(Friedman & Chrousos, 1993). Therefore, when in 
immediate postoperative period the morning serum cortisol 
level and 24-hour urinary cortisol excretion are in the normal
range or when one of these parameters is normal and the other 
below normal, the conclusion that surgery has failed is not 
necessarily justified. In a substantial number of these patients 
an early clinical remission may be observed (Vignati et al., 
1994) and some o f them may be really cured. Caution is also 
needed in the interpretation of the low-dose dexamethasone test 
postoperatively. Failure to suppress with dexamethasone in the 
early postoperative period, but normal suppressibility later, and 
a course compatible with cure have been reported (McDonald et 
al., 1978). On the other hand, persistent Cushing’s disease after 
operation, despite full suppression with dexamethasone, has 
also been described (Jeffcoate et al., 1985). Furthermore, a 
normal postoperative low-dose dexamethasone test certainly 
does not exclude a late relapse o f the disease (Vignati et al.,
1994).
Biochemical testing in the immediate postoperative period is 
also valuable as an early marker o f the risk of relapse. Patients 
who relapse after an initial remission have significantly higher 
morning serum cortisol levels, as well as 24-hour urinary 
cortisol excretion in the immediate postoperative period than 
patients who do not relapse. However, there is considerable 
overlap between values recorded in patients who do and those 
who do not relapse (Pieters et al., 1989; Vignati et til., 1994). It 
has been claimed that the finding of ACTH hyperresponsive­
ness in an early postoperative CRH test is more valuable for 
identifying patients at risk o f recurrence of Cushing’s disease 
than measurement o f basal cortisol levels (Vignati et al., 1994). 
Again, however, there is considerable overlap in responses 
between patients who do and those who do not relapse. The 
strongest predictor o f cure seems to be the finding of an
serum cortisol in immediate
operative period. No recurrences were reported in 2 recent
an time of follow-up 40 and 90 months,
respectively) in patients who had undetectable serum cortisol
(Trainer et a l .,in
1993; McCance et ul., s was not in
European i study, in which the disease recurred
during follow-up in 4-3% of with
et
1995). However, information on the detection limits and other 
performance characteristics o f  the cortisol assays used in the 
participating centres was not given in this study,
The study of Van Aken et cil., (1997) confirms the limitations 
o f the morning serum cortisol level and the 24-hour urinary 
cortisol excretion in the immediate postoperative period as 
predictors o f the early and late outcome o f pituitary surgery for
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Cushing’s disease. Early remission of Cushing’s disease was 
seen in a few patients with a normal morning serum cortisol 
level or normal 24-hour urinary cortisol excretion. Further­
more, serum and urinary cortisol levels in the immediate 
postoperative period were in the same range in the 3 patients 
who had a relapse o f Cushing’s disease after an initial remission 
as in the patients who remained in remission. Interestingly, in 
the study of Van Aken et al., the metyrapone test completely 
separated patients who had an early remission of Cushing’s 
disease after pituitary surgery and those who had not. More­
over, the metyrapone test was useful for the early detection of 
patients at risk o f a relapse: all 3 patients who had a recurrence 
of Cushing’s disease had a serum 11 -deoxycortisol level 
>150 nmol/1 after metyrapone and of 14 patients who remained 
in remission only one had a serum 11-deoxycortisol level 
>150 nmol/1 after metyrapone. Although these results are 
promising, it concerns a retrospective study in which only 29 
of 77 consecutive patients were included and median follow-up 
was only 35 months.
No single diagnostic test can separate all patients with 
untreated Cushing’s disease from healthy subjects. Similarly, it 
is doubtful whether in the postoperative period 1 single test will 
be able to assess reliably the early outcome of pituitary surgery 
for Cushing’s disease and to predict all recurrences o f the 
disease. Prospective studies with a large number o f patients and 
long follow-up times are needed to determine which combina­
tion of clinical and laboratory data will come close to this goal.
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